Your browser doesn't support javascript.
loading
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
Laribi, Kamel; Tempescul, Adrien; Ghnaya, Habib; Denizon, Nathalie; Besançon, Anne; Anghel, Andreea; Farhi, Jonathan; Truong, Catherine; Lemaire, Pierre; Poulain, Stephanie; Bolle, Delphine; Ianotto, Jean Christophe; Baugier de Materre, Alix.
Afiliação
  • Laribi K; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Tempescul A; Department of Hematology, Institut de Cancéro-Hématologie, CHRU Brest, Brest, France.
  • Ghnaya H; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Denizon N; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Besançon A; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Anghel A; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Farhi J; Department of Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Truong C; Clinical Research Center, Centre Hospitalier du Mans, Le Mans, France.
  • Lemaire P; Laboratory of Biology and Hematology, Centre Hospitalier du Mans, Le Mans, France.
  • Poulain S; Service d'Hématologie-Immunologie-Cytogénétique, Centre Hospitalier de Valenciennes, Valenciennes, France.
  • Bolle D; Laboratoire d'Hématologie, Centre de Biologie et Pathologie, CHRU de Lille, Lille, France.
  • Ianotto JC; INSERM UMR 1172, IRCL, Lille, France.
  • Baugier de Materre A; Department of Pharmacy, Centre Hospitalier du Mans, Le Mans, France.
Hematol Oncol ; 35(4): 536-541, 2017 Dec.
Article em En | MEDLINE | ID: mdl-27443419

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Cloridrato de Bendamustina / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Cloridrato de Bendamustina / Rituximab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França